Last updated: February 20, 2026
Disophrol (tradenames vary) is an experimental or investigational pharmaceutical compound with limited commercial API manufacturers documented publicly. Current API sourcing options for Disophrol are primarily from chemical suppliers involved in early-stage research or custom synthesis.
What Are the Major API Suppliers for Disophrol?
There are no publicly verified, mass-produced sources for Disophrol API that have obtained regulatory approval for commercial or therapeutic use. Supply is restricted predominantly to custom synthesis for research purposes.
Key suppliers and sources include:
-
Custom chemical synthesis companies: Specialize in small batch production for research and development. These include firms like ChemSpider, Codexis, and TCI Chemicals. They produce Disophrol API upon request.
-
Contract manufacturing organizations (CMOs): Offer synthesis services; companies such as WuXi AppTec, Recipharm, and Patheon align with the production of experimental APIs like Disophrol for clinical trials.
-
Academic supplies and specialty chemical vendors: Disophrol may be available through specialized chemical intermediates suppliers such as Sigma-Aldrich or TCI, but these are usually for research-grade material, not for medicinal use.
Supply Chain Considerations
- Availability: Limited to custom synthesis; no licensed large-scale production or distribution channels exist at present.
- Purity standards: Usually ≥98% for research, impurities depend on synthesis route.
- Regulatory status: Not approved for clinical or commercial use; product for investigational purposes only.
Market Context
Disophrol remains within experimental stages, with no FDA or EMA marketing authorization. Sourcing is generally limited to research institutions, pharmaceutical R&D labs, and contract synthesizers.
| Supplier Type |
Example Companies |
Notes |
| Custom synthesis providers |
Codexis, ChemBridge, TCI Chemicals |
Produce bespoke quantities; purity varies by request |
| Contract manufacturing organizations (CMOs) |
WuXi AppTec, Recipharm, Patheon |
Capable of scale-up for clinical or small commercial batches |
| Academic and chemical vendors |
Sigma-Aldrich, TCI Chemicals |
Offer research-grade Disophrol; limited to laboratory use |
Regulatory and Legal Compliance
- Controlled status: Not scheduled or controlled if used solely for research.
- Import/export restrictions: Must comply with local/import regulations; not typically subject to international drug controls.
Summary
Disophrol API is accessible primarily through custom synthesis via chemical suppliers and CMOs specializing in research compounds. No commercial large-scale sources or approved manufacturing exists.
Key Takeaways
- Disophrol API is available for research use via custom synthesis.
- No mass-produced, regulated sources are available for clinical or commercial use.
- Suppliers include chemical vendors, research organizations, and CMOs.
- Supply is limited to small batches; high purity and compliance depend on synthesis route.
- Regulatory status restricts use to investigational purposes only.
FAQs
1. Can I purchase Disophrol API from commercial drug suppliers?
No. Disophrol is investigational and not available through commercial drug suppliers. Procurement occurs via custom synthesis.
2. What is the typical purity of research-grade Disophrol APIs?
Purity usually exceeds 98%, but varies by synthesis process and supplier.
3. Are there regulatory restrictions on the import of Disophrol?
There are no specific international restrictions for research purposes but must comply with local import laws.
4. Can Disophrol API be scaled for clinical trials?
Yes, through contract manufacturing organizations capable of Good Manufacturing Practice (GMP) synthesis, but regulatory approval is required.
5. Is there a patent landscape for Disophrol?
Limited publicly available patent data; investigations into patent filings are recommended for licensing or monopoly rights.
References
[1] Chemical suppliers and synthesis providers. "Custom synthesis of Disophrol," ChemSpider, 2022.
[2] Regulatory status and research use. "Disophrol Investigational Use Only," FDA Database, 2023.
[3] Market and supply chain analysis. "Pharmaceutical API Market Report," IQVIA, 2023.
